<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04104815</url>
  </required_header>
  <id_info>
    <org_study_id>DA26</org_study_id>
    <nct_id>NCT04104815</nct_id>
  </id_info>
  <brief_title>GI Tolerance and Acceptability of a New Thickener</brief_title>
  <official_title>A Study to Evaluate the GI Tolerance and Acceptability of a New Thickener for Dysphagia Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study is designed to evaluate the gastrointestinal tolerance and acceptability of
      a new thickener for dysphagia patients.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bristol Stool Scale</measure>
    <time_frame>Study Day 1 to Study Day 7</time_frame>
    <description>The Bristol Stool Scale is used to describe the consistency of stools. Numbers 1-7 are assigned to stools based on descriptions on the scale from hard to liquid.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HCP Product Satisfaction Questionnaire</measure>
    <time_frame>Study Day 7</time_frame>
    <description>5 Questions; 3 of the questions utilize a 5 point scale in the positive direction; 2 of the questions are closed categories yes or no.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Palatability of Study Product</measure>
    <time_frame>Study Day 1 and Study Day 7</time_frame>
    <description>A 5 point scale in the positive direction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Product Compliance</measure>
    <time_frame>Study Day 1 to Study Day 7</time_frame>
    <description>Patient thickened fluids consumption records</description>
  </primary_outcome>
  <other_outcome>
    <measure>Weight</measure>
    <time_frame>Study Day 1 and Study Day 7</time_frame>
    <description>Weight in Kg</description>
  </other_outcome>
  <other_outcome>
    <measure>Medications</measure>
    <time_frame>Study Day 1 to Study Day 7</time_frame>
    <description>Current medication use</description>
  </other_outcome>
  <other_outcome>
    <measure>Thickness of drinks prescribed</measure>
    <time_frame>Study Day 1 to Study Day 7</time_frame>
    <description>Current prescription per IDDSI guidelines</description>
  </other_outcome>
  <other_outcome>
    <measure>Medical aetiology of dysphagia</measure>
    <time_frame>Study Day 1 and Study Day 7</time_frame>
    <description>Current documentation of medical aetiology</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">19</enrollment>
  <condition>Gastro-intestinal Tolerance</condition>
  <arm_group>
    <arm_group_label>Experimental Thickener</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Powder thickener</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Thickener</intervention_name>
    <description>Use to thicken liquids</description>
    <arm_group_label>Experimental Thickener</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has voluntarily signed and dated an ICF approved by an IRB/IEC, and provided
             applicable privacy authorization prior to any participation in the study.

          -  Subject is diagnosed with dysphagia.

          -  Subject is under the care of a Speech and Language Therapist and is currently using a
             thickener.

          -  Subject currently has normal GI function.

          -  Subject is interested in participating in the study, willing to comply with the study
             protocol and product.

          -  Subject who is able to consent and is able to evaluate the product.

        Exclusion Criteria:

          -  Subject has a normal swallow.

          -  Subject at high risk of aspiration with oral fluids requiring nil by mouth and enteral
             tube feeding.

          -  Subject has impaired renal function.

          -  Subject has liver failure, decompensated chronic liver disease, active hepatitis B or
             C receiving treatment, or hepatic encephalopathy.

          -  Subject has severe dementia or unable to communicate or consent or delirium, eating
             disorder, history of significant neurological or psychiatric disorder affecting
             abilities to answer questions, alcoholism, substance abuse or other conditions that
             may interfere with study product consumption or compliance with study protocol
             procedures.

          -  Participant is known to be allergic or intolerant to any ingredient found in the study
             product.

          -  Participation in another study that has not been approved as a concomitant study.

          -  Subject has a clinical condition that is contraindicated with this product such as
             hepatic and renal disease.

          -  Subject has a clinical condition which may interfere with gastrointestinal tolerance.

          -  Subject is pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca Stevenson</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen DeLuca, MS, RDN, LD</last_name>
    <phone>614-624-5455</phone>
    <email>kristen.deluca@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Royal Derby Hospital Centre</name>
      <address>
        <city>Derby</city>
        <zip>DE22 3DT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>September 24, 2019</study_first_submitted>
  <study_first_submitted_qc>September 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2019</study_first_posted>
  <last_update_submitted>February 17, 2020</last_update_submitted>
  <last_update_submitted_qc>February 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

